The blockage of the interaction between SCF and its receptor (c-Kit) by anti-c-Kit prevents tumor-specific T-cell anergy, regulatory T (Treg) cell development, and tumor angiogenesis [77]. The gene discussed is KIT; the disease is neoplasm.